Show simple item record

Bortezomib-based therapy for relapsed/refractory multiple myeloma in real-world medical practice

dc.contributor.authorSpencer, Mike
dc.contributor.authorDimopoulos, Meletios A.
dc.contributor.authorRobinson, Don
dc.contributor.authorPotamianou, Anna
dc.contributor.authorvan de Velde, Helgi
dc.contributor.authorSargin, Deniz
dc.contributor.authorTerpos, Evangelos
dc.contributor.authorKatodritou, Eirini
dc.contributor.authorde la Rubia, Javier
dc.contributor.authorHungria, Vania
dc.contributor.authorHulin, Cyrille
dc.contributor.authorRoussou, Maria
dc.contributor.authorDelforge, Michel
dc.contributor.authorBries, Greet
dc.contributor.authorStoppa, Anne-Marie
dc.contributor.authorAagesen, Jesper
dc.contributor.authorBelch, Andrew
dc.contributor.authorAhlberg, Lucia
dc.contributor.authorDiels, Joris
dc.contributor.authorOlie, Robert A.
dc.date.accessioned2021-03-06T07:43:52Z
dc.date.available2021-03-06T07:43:52Z
dc.date.issued2018
dc.identifier.citationTerpos E., Katodritou E., de la Rubia J., Hungria V., Hulin C., Roussou M., Delforge M., Bries G., Stoppa A., Aagesen J., et al., "Bortezomib-based therapy for relapsed/refractory multiple myeloma in real-world medical practice", EUROPEAN JOURNAL OF HAEMATOLOGY, cilt.101, ss.556-565, 2018
dc.identifier.issn0902-4441
dc.identifier.othervv_1032021
dc.identifier.otherav_dd9e9334-2cc6-4832-82cb-a0a849885dfc
dc.identifier.urihttp://hdl.handle.net/20.500.12627/146016
dc.identifier.urihttps://doi.org/10.1111/ejh.13147
dc.description.abstractObjective: The efficacy and safety of bortezomib-based therapy for relapsed/refractory multiple myeloma (RRMM) in clinical trials may differ from the oncology practice experience. The electronic VELCADE (R) OBservational Study was designed to prospectively evaluate bortezomib for multiple myeloma (MM) in real-world medical practice.
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectHematoloji
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectHEMATOLOJİ
dc.titleBortezomib-based therapy for relapsed/refractory multiple myeloma in real-world medical practice
dc.typeMakale
dc.relation.journalEUROPEAN JOURNAL OF HAEMATOLOGY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume101
dc.identifier.issue4
dc.identifier.startpage556
dc.identifier.endpage565
dc.contributor.firstauthorID257704


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record